(MedPage Today) -- DENVER -- A majority of patients with non-locally treated brain metastases from kidney cancer remained free of metastatic progression for at least 6 months when treated with cabozantinib (Cabometyx), a small prospective…
(MedPage Today) -- DENVER -- A discussion about patient-centered issues in kidney cancer management focused considerable attention on the controversial antiparasitic ivermectin, which was not even on the program at the International Kidney…
The study sought to answer questions about how breast cancer risk differs by type of hormonal contraceptive. Doctors say the results won't change how they counsel patients.
People in England with a learning disability have a higher risk of cancer, especially before age 50 , according to a study by researchers from The University of Manchester and The ChristieNHS Foundation Trust .
Melanoma remains one of the hardest skin cancers to diagnose because it often mimics harmless moles or lesions. While most artificial intelligence (AI) tools rely on dermoscopic images alone, they often overlook crucial patient information…
Patient-derived xenograft (PDX) models are emerging as a transformative tool in colorectal cancer (CRC) research, offering unparalleled insights into tumor biology, drug resistance, and personalized treatment approaches.
(MedPage Today) -- Patients with colon cancer and a history of treatment with GLP-1 receptor agonists for obesity had a 5-year mortality rate that was less than half the rate for patients who didn't take these drugs, according to a large…
New results from a multicenter clinical trial show that combining immunotherapy drugs nivolumab and ipilimumab significantly improves treatment response in patients with advanced and difficult-to-treat cancers. The trial results have been…
GLP-1 medications may help colon cancer patients live longer by reducing inflammation and improving metabolic health, UC San Diego researchers found in a 6,800-patient study.
The TAR‑200 slow‑release bladder implant cleared tumours in 82% of patients with high‑risk non‑muscle‑invasive bladder cancer, offering a promising new treatment approach.
A new Cedars-Sinai Cancer study shows that patients with advanced liver cancer who receive immunotherapy to shrink their tumors have improved outcomes after liver transplant or tumor removal.
People in England with a learning disability have a higher risk of cancer, especially before age 50, according to a study by researchers from The University of Manchester and The ChristieNHS Foundation Trust.